|4Mar 12, 7:13 PM ET

Friedland Jeffrey 4

4 · Intiva BioPharma Inc. · Filed Mar 12, 2018

Insider Transaction Report

Form 4
Period: 2018-03-08
Friedland Jeffrey
DirectorChief Executive Officer10% Owner
Transactions
  • Disposition to Issuer

    Common Stock

    2018-03-081,166,667833,333 total
Holdings
  • Class B Warrants (right to buy)

    (indirect: By LLC)
    Exercise: $0.38From: 2017-11-29Exp: 2018-05-07Common Stock (20,800 underlying)
    20,800
  • Common Stock

    (indirect: By LLC)
    228,800
  • Class C Warrants (right to buy)

    (indirect: By LLC)
    Exercise: $0.50From: 2017-11-29Exp: 2018-07-14Common Stock (20,800 underlying)
    20,800
  • Common Stock

    (indirect: By Intiva USA Inc.)
    24,000,000
Footnotes (1)
  • [F1]Mr. Friedland resigned as an officer and director on March 8, 2018, thereby causing his unvested shares granted under the Company's Stock Incentive Plan to be forfeited and returned to the Company for cancellation.

Documents

1 file
  • 4
    marketforms-41386.xmlPrimary

    PRIMARY DOCUMENT